首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Knowledge, attitudes, beliefs and practices of general practitioners towards measles and MMR vaccination in southeastern France in 2012
【24h】

Knowledge, attitudes, beliefs and practices of general practitioners towards measles and MMR vaccination in southeastern France in 2012

机译:2012年法国东南部全科医生对麻疹和MMR疫苗接种的知识,态度,信念和做法

获取原文
获取原文并翻译 | 示例
           

摘要

As a result of sub-optimal immunization levels, measles has re-emerged in the EU since 2008 (30 567 cases in 2011), and nearly half of the cases reported are in France. Our objectives were to assess knowledge, attitudes, beliefs and practices of French general practitioners (GPs) towards measles and measles-mumps-rubella (MMR) vaccination. In 2012, we surveyed 329 GPs in southeastern France. Forty-five percent reported that they saw patients with measles in 2011. They considered the risk of complications low among 2-5-year-old children and young adults without co-morbidity. Twenty percent knew that two MMR doses are 99% effective in preventing measles. Nearly all (95%) GPs stated that they verified the MMR status for patients <30 years old in 2011 (42% systematically, 37% often, 15% sometimes). Seventy-nine percent reported proposing MMR vaccination to non-immune relatives in contact with a patient with measles. Participation in continuing medical education courses and considering measles to be a serious disease were independently associated with such post-exposure vaccination. GPs considered the following were potential barriers to the second dose of MMR (MMR2): parents/patients' belief that measles is harmless (80%), parents/patients' fear of the vaccine's side effects (50%), difficulty in documenting vaccination (48%) and lack of reminders for MMR2 (16%). Finally, some GPs also had misconceptions about the severity of measles (13%) and the usefulness of MMR2 (12%), which also served as barriers. In conclusion, it is essential to raise GPs' awareness of this disease and fill any gaps in their knowledge, by providing them with evidence-based information on measles and MMR vaccination.
机译:由于次优免疫水平,麻疹自2008年以来在欧盟重新出现(2011年为30 567例),报告的病例中近一半在法国。我们的目标是评估法国全科医生(GPs)对麻疹和麻疹-腮腺炎-风疹(MMR)疫苗接种的知识,态度,信念和做法。 2012年,我们对法国东南部的329名GP进行了调查。 45%的人报告说,他们在2011年看到了麻疹患者。他们认为2-5岁的儿童和没有合并症的年轻人中发生并发症的风险较低。 20%的人知道两次MMR剂量可有效预防麻疹99%。几乎所有(95%)的GP均表示,他们在2011年验证了30岁以下患者的MMR状况(系统地为42%,经常为37%,有时为15%)。 79%的人报告建议与麻疹患者接触的非免疫亲戚接种MMR疫苗。参加这种继续接触后的疫苗接种独立地涉及继续医学教育课程并认为麻疹是一种严重疾病。全科医生认为以下是第二次MMR(MMR2)的潜在障碍:父母/患者认为麻疹无害(80%),父母/患者担心疫苗的副作用(50%),难以记录疫苗接种(48%)和缺乏MMR2提醒(16%)。最后,一些全科医生对麻疹的严重程度(13%)和MMR2的有效性(12%)也有误解,这也是障碍。总之,至关重要的是,通过向全科医生提供有关麻疹和MMR疫苗接种的循证信息,提高全科医生对这种疾病的认识并填补其知识的空白。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号